Skip to content

Author

M. Gümüş

We have 2 of 98 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Pembrolizumab Plus Chemotherapy for Cervical Cancer: An Exploratory Analysis of the KEYNOTE-826 Randomized Clinical Trial.

Importance In the KEYNOTE-826 study, pembrolizumab (vs placebo) plus platinum-based chemotherapy (with or without bevacizumab) significantly improved progression-free survival and overall survival in participants with previously untreated persistent, recurrent, or metastatic cervical cancer at interim analysis 1 (media...

Kosei Hasegawa, N. Colombo, Krishnansu S. Tewari et al. · 0 citations
2026

Evaluation of AI-Derived Survival Estimates Against Real-World Outcomes in Extensive-Stage Small Cell Lung Cancer

AI-derived survival estimates based on baseline data tend to overestimate survival and show limited agreement with real-world outcomes in extensive-stage SCLC, suggesting these tools may provide general prognostic insight but are not yet suitable for independent clinical decision-making.

Fatih Atalah, M. Gümüş · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.